News

Stars Insider on MSN3h
FDA approved: New medications and vaccines
Alzheimer's patients have new hope with Kisunla and Zunveyl, which target the disease in unprecedented ways, while Dupixent ...
The Pharma Letter18h
Dupixent demonstrated superiority over Xolair in chronic rhinosinusitis
French pharma major Sanofi and US partner Regeneron Pharmaceuticals yesterday presented positive results from the EVEREST ...